Research

Clinical Research:

• FIGARO-DKD Study: Randomized, double blind, placebo-controlled study of high affinity mineralocorticoid receptor antagonist, Finerenone, in cardiovascular events in diabetic subjects


• The Diabetes LIFEMAP: Transforming Diabetes Care for the 21st Century


• Evaluating the effect of medication compliance on the risk of ASCVD in diabetes: Retrospective chart review from Epic database

Publications (Last 3 years):

• DiagnosisDiagnosis of cyclic Cushing's disease manifests as early morning hyperglycemia in a patient with previously well-controlled type 1 diabetes. Singer-Granick C, Liu JK, Bleich D, Cespedes L. J Pediatr Endocrinol Metab. 2019 Jul 26;32(7):785-789. doi: 10.1515/jpem-2018-0506


• Intensive Glucose Control in Patients with Type 2 Diabetes - 15-Year Follow-up. Reaven PD, Emanuele NV, Wiitala WL, Bahn GD, Reda DJ, McCarren M, Duckworth WC, Hayward RA; VADT Investigators. N Engl J Med. 2019 Jun 6;380(23):2215-2224. doi: 10.1056/NEJMoa1806802.


• Endothelial Cell Growth Promoting Activity in Graves' Disease Sera is Neutralized by Anti-Basic Fibroblast Growth Factor Antibodies in Patients with Fat Expansive but Not Infiltrative Orbitopathy.Zimering MB, Shin JJ, Zaitz JD, Nunez EA, Gianoukakis AG. Endocrinol Diabetes Metab J. 2019 Feb;3(1)


• Challenges to Reshape the Future of Type 1 Diabetes Research. Bleich D, Wagner DH. J Clin Endocrinol Metab. 2018 Aug 1;103(8):2838-2842. doi: 10.1210/jc.2018-00568. Review.


• Thyroid Hormone Resistance in Identical Twin Sisters with Atrial Fibrillation: Case Report and Review of the Literature. Zimering MB. J Endocrinol Diabetes. 2018;5(4). doi: 10.15226/2374-6890/5/4/01111. Epub 2018 Jul 23.


• Circulating Neurotoxic 5-HT2A Receptor Agonist Autoantibodies in Adult Type 2 Diabetes with Parkinson's Disease. Zimering MB. J Endocrinol Diabetes. 2018;5(2). doi: 10.15226/2374-6890/5/2/01102. Epub 2018 May 10.


• Diabetes Autoantibodies Mediate Neural- and Endothelial Cell- Inhibitory Effects Via 5-Hydroxytryptamine- 2 Receptor Coupled to Phospholipase C/Inositol Triphosphate/Ca2+ Pathway. Zimering MB. J Endocrinol Diabetes. 2017;4(4). doi: 10.15226/2374-6890/4/4/00184. Epub 2017 Oct 4


• TIMP-1 and CD82, a promising combined evaluation marker for PDAC. Zhang J, Wu T, Zhan S, Qiao N, Zhang X, Zhu Y, Yang N, Sun Y, Zhang XA, Bleich D, Han X. Oncotarget. 2017 Jan 24;8(4):6496-6512. doi: 10.18632/oncotarget.14133.

Abstracts (Last 2 years):

• Necrotizing Pancreatitis an unusual presentation of a long standing primary hyperparathyroidism by Fadwa Sumrein, DO, Maya Raghuwanshi MD, MPH


• Transient hepatotoxicity and severe hypertriglyceridemia seen after over the counter testosterone Booster supplement” T. Razzaki, MD, M. Raghuwanshi, MD, MPH


• An Interesting Case of Metastatic Papillary Thyroid Cancer and Concomitant Medullary Micro-carcinoma. Fadwa Sumrein, Lissette Cespedes.


• Hypogonadism in Mauriac Syndrome. Shalem L, Bleich D, Raghuwanshi M


• A Case of Fibrous Variant of Hashimoto’s Thyroiditis. Khutorsky T and Bleich D.


• Duodenal Somatostatinoma and Primary Hyperparathyroidism: An Interesting Case Report. Sumrein, F., Céspedes, L.


• Brachial Plexopathy: A Rare Presentation of Metastatic Papillary Thyroid Cancer. Faheem, M., Céspedes, L


• Poorly Differentiated Thyroid Cancer: A Diagnostic Dilemma. Razzaki, T., Céspedes, L.